Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report

The current Food and Drug Administration-approved systemic treatments for advanced hepatocellular carcinoma (HCC) include multikinase inhibitors (tyrosine kinase inhibitor [TKI]) and immune checkpoint inhibitors (ICIs). Among ICIs, nivolumab is used as second-line therapy for advanced HCC after sora...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji Eun, Cho, Hyo Jung, Kim, Soon Sun, Cheong, Jae Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Liver Cancer Association 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035689/
https://www.ncbi.nlm.nih.gov/pubmed/37383079
http://dx.doi.org/10.17998/jlc.2021.08.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035689/
https://www.ncbi.nlm.nih.gov/pubmed/37383079
http://dx.doi.org/10.17998/jlc.2021.08.26

Ejemplares similares